Table 6 Multivariable analysis of survival predictors for patients with synchronous multiple lung adenocarcinoma.
From: Surgical Outcomes of Synchronous Multiple Primary Non-Small Cell Lung Cancers
Variables | Disease free survival | Overall survival | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Subtypes of largest tumor | <0.001 | <0.001 | ||||
Lepidic predominant | 1.00 | Reference | 1.00 | Reference | ||
Acinar predominant | 3.18 | 0.89–11.33 | 6.36 | 0.76–53.57 | ||
Papillary predominant | 2.72 | 0.54–13.65 | 2.79 | 0.17–45.21 | ||
Micropapillary predominant | 25.16 | 2.83–223.71 | 25.56 | 1.10–595.43 | ||
Solid predominant | 23.41 | 5.75–95.24 | 51.57 | 5.85–454.64 | ||
pN stage | <0.001 | 0.002 | ||||
0 | 1.00 | Reference | 1.00 | Reference | ||
1 | 1.36 | 0.39–4.76 | 1.06 | 0.22–5.03 | ||
2 | 6.67 | 2.91–15.32 | 7.41 | 2.35–23.43 | ||
